Terms: = Prostate cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Diagnosis
14 results:
1. Cross-Sectional Analysis of the Associations Between Four Common cancers and Disability.
Iezzoni LI; Rao SR; Agaronnik ND; El-Jawahri A
J Natl Compr Canc Netw; 2020 Aug; 18(8):1031-1044. PubMed ID: 32755976
[TBL] [Abstract] [Full Text] [Related]
2. Extremely rare synchronous primary neoplasms in testicular cancer patients.
Mrinakova B; Ondrusova M; Lehotska V; Ondrus D
Bratisl Lek Listy; 2019; 120(9):641-645. PubMed ID: 31475546
[TBL] [Abstract] [Full Text] [Related]
3. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract] [Full Text] [Related]
4. Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam apps.
De Nunzio C; Lombardo R; Tema G; Cancrini F; Russo GI; Chacon R; Garcia-Cruz E; Ribal MJ; Morgia G; Alcaraz A; Tubaro A
Eur J Surg Oncol; 2019 Mar; 45(3):471-476. PubMed ID: 30343993
[TBL] [Abstract] [Full Text] [Related]
5. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
Elshafei A; Chevli KK; Moussa AS; Kara O; Chueh SC; Walter P; Hatem A; Gao T; Jones JS; Duff M
Prostate; 2015 Dec; 75(16):1951-7. PubMed ID: 26384170
[TBL] [Abstract] [Full Text] [Related]
6. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
Haluskova J; Lachvac L; Nagy V
Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
[TBL] [Abstract] [Full Text] [Related]
7. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract] [Full Text] [Related]
8. The natural history of prostate cancer.
Kessler B; Albertsen P
Urol Clin North Am; 2003 May; 30(2):219-26. PubMed ID: 12735499
[TBL] [Abstract] [Full Text] [Related]
9. prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database.
Stephenson RA
Urol Clin North Am; 2002 Feb; 29(1):173-81. PubMed ID: 12109343
[TBL] [Abstract] [Full Text] [Related]
10. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy.
Takayama TK; Lange PH
Urol Clin North Am; 1994 Nov; 21(4):687-700. PubMed ID: 7526515
[TBL] [Abstract] [Full Text] [Related]
11. Stage T1A carcinoma of prostate.
Matzkin H; Patel JP; Altwein JE; Soloway MS
Urology; 1994 Jan; 43(1):11-21. PubMed ID: 8284869
[TBL] [Abstract] [Full Text] [Related]
12. Cytogenetics of prostate cancer. Consensus Conference on diagnosis and Prognostic Parameters in Localized prostate cancer. Stockholm, Sweden, May 12-13, 1993.
Debruyne FM; Collins VP; van Dekken H; Jenkins RB; Klocker H; Schalken JA; Sesterhenn IA
Scand J Urol Nephrol Suppl; 1994; 162():65-71; discussion 115-27. PubMed ID: 7817161
[TBL] [Abstract] [Full Text] [Related]
13. [A screening program for the diagnosis of early forms of prostatic carcinoma].
Zvara P; Hornák M
Bratisl Lek Listy; 1992 Nov; 93(11):585-8. PubMed ID: 1291042
[TBL] [Abstract] [Full Text] [Related]
14. Ultrastructural characterization of pulmonary neoplasms. II. The role of electron microscopy in characterization of uncommon epithelial pulmonary neoplasms, metastatic neoplasms to and from lung, and other tumors, including mesenchymal neoplasms.
Herrera GA; Alexander CB; Jones JM
Surv Synth Pathol Res; 1985; 4(2):163-84. PubMed ID: 2996107
[TBL] [Abstract] [Full Text] [Related]
